We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+16.31%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
Cap. Flow
+$13.4M
Cap. Flow %
9.95%
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
FOLD icon
Amicus Therapeutics
FOLD
+$5.57M
2
ALCO icon
Alico
ALCO
+$2.28M
3
ELTX icon
Elicio Therapeutics
ELTX
+$1.81M
4
EXEL icon
Exelixis
EXEL
+$1.81M
5
MRK icon
Merck
MRK
+$1.47M

Top Sells

Rank Stock Value
1
ATER icon
Aterian
ATER
+$7.86M
2
AVNW icon
Aviat Networks
AVNW
+$3.95M
3
CLPT icon
ClearPoint Neuro
CLPT
+$3.34M
4
INTC icon
Intel
INTC
+$2.49M
5
GILD icon
Gilead Sciences
GILD
+$1.75M

Sector Composition

Rank Sector Weight
1 Healthcare 40.52%
2 Financials 13.92%
3 Technology 12.69%
4 Energy 10.02%
5 Materials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PRU icon
51
Prudential Financial
PRU
$40.1B
$1.09M 0.81%
+12,000
New +$1.03M
2021 Q1
0 quarters
PRTK
52
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.06M 0.79%
150,000
+115,000
+329% +$828K
2020 Q4
1 quarter
VTLE icon
53
DELISTED
Vital Energy
VTLE
$1.05M 0.78%
35,000
– –
2020 Q4
1 quarter
IAG icon
54
IAMGOLD
IAG
$10.1B
$1.04M 0.78%
350,000
+150,000
+75% +$496K
2020 Q4
1 quarter
CTSO icon
55
Cytosorbents Corp
CTSO
$9.64M
$1.04M 0.77%
+6,000
New +$1.14M
2021 Q1
0 quarters
TBPH icon
56
DELISTED
Theravance Biopharma
TBPH
$1.02M 0.76%
+50,000
New +$950K
2021 Q1
0 quarters
NKTR icon
57
Nektar Therapeutics
NKTR
$1.29B
$1M 0.74%
3,333
+1,000
+43% +$311K
2020 Q4
1 quarter
ACNB icon
58
ACNB Corp
ACNB
$643M
$996K 0.74%
+34,000
New +$952K
2021 Q1
0 quarters
YARW
59
Yarrow Bioscience
YARW
$169M
$984K 0.73%
160
-19
-11% -$138K
2020 Q4
1 quarter
SPPI
60
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$978K 0.73%
300,000
+50,000
+20% +$179K
2020 Q4
1 quarter
BCEL
61
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$920K 0.68%
60,000
– –
2020 Q4
1 quarter
SMSI icon
62
Smith Micro Software
SMSI
$12.9M
$881K 0.65%
4,000
-1,000
-20% -$264K
2020 Q4
1 quarter
CSOD
63
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$872K 0.65%
+20,000
New +$921K
2021 Q1
0 quarters
MTG icon
64
MGIC Investment
MTG
$5.66B
$831K 0.62%
+60,000
New +$765K
2021 Q1
0 quarters
HRTX icon
65
Heron Therapeutics
HRTX
$71.5M
$811K 0.6%
50,000
+35,000
+233% +$624K
2020 Q4
1 quarter
ELDN icon
66
Eledon Pharmaceuticals
ELDN
$184M
$803K 0.6%
+75,000
New +$1.13M
2021 Q1
0 quarters
TVTX icon
67
Travere Therapeutics
TVTX
$4.98B
$799K 0.59%
32,000
– –
2020 Q4
1 quarter
CBAY icon
68
DELISTED
Cymabay Therapeutics
CBAY
$681K 0.51%
+150,000
New +$807K
2021 Q1
0 quarters
FLXN icon
69
DELISTED
Flexion Therapeutics, Inc.
FLXN
$671K 0.5%
75,000
– –
2020 Q4
1 quarter
PAGP icon
70
Plains GP Holdings
PAGP
$5.38B
$658K 0.49%
70,000
+45,000
+180% +$420K
2020 Q4
1 quarter
SRCE icon
71
1st Source
SRCE
$2.06B
$571K 0.42%
12,000
– –
2020 Q4
1 quarter
PLPC icon
72
Preformed Line Products
PLPC
$1.81B
$550K 0.41%
8,000
+2,830
+55% +$198K
2020 Q4
1 quarter
HGEN
73
DELISTED
HUMANIGEN, INC.
HGEN
$478K 0.36%
25,000
-15,000
-38% -$274K
2020 Q4
1 quarter
EQT icon
74
EQT Corp
EQT
$32.8B
$465K 0.35%
+25,000
New +$435K
2021 Q1
0 quarters
CTRA icon
75
DELISTED
Coterra Energy
CTRA
$376K 0.28%
+20,000
New +$368K
2021 Q1
0 quarters
1 2
3
4 5

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q1 2021 Portfolio in Review

As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.

  • CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
  • CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
  • CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
  • CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
  • CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
  • CM Management opened 21 new positions and closed 20 in Q1 2021.
  • CM Management's portfolio value rose 25% quarter-over-quarter to $135M.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.